TY  - GEN
AU  - Na,Young-Soon
AU  - Jung,Kyung-Ah
AU  - Kim,Seung-Mi
AU  - Hong,Yong Sang
AU  - Ryu,Min-Hee
AU  - Jang,Se Jin
AU  - Moon,Dae Hyuk
AU  - Cho,Dong-Hyung
AU  - Kim,Jin Cheon
AU  - Lee,Jung Shin
AU  - Kim,Tae Won
TI  - The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models
SN  - 1432-0843
PY  - 2011///1003
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Apoptosis
KW  - drug effects
KW  - Camptothecin
KW  - Cell Proliferation
KW  - Colonic Neoplasms
KW  - drug therapy
KW  - Drug Synergism
KW  - Female
KW  - HCT116 Cells
KW  - HT29 Cells
KW  - Histone Deacetylase Inhibitors
KW  - Humans
KW  - Hydroxamic Acids
KW  - Irinotecan
KW  - Mice
KW  - Mice, Nude
KW  - Prodrugs
KW  - Random Allocation
KW  - Sulfonamides
KW  - Topoisomerase I Inhibitors
KW  - Tumor Burden
KW  - Whole Body Imaging
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-010-1495-6
ER  -